ADAR1 Capital Management »

Aurinia Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $10k 2.0k 5.01

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Aurinia Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Tang Capital Management
NEA Management Company
State Street Corporation
Goldman Sachs Group
Nuveen Asset Management
Geode Capital Management
Vanguard Group
Rock Springs Capital Management
Susquehanna International
Citadel Advisors
Schroder Investment Management Group
Northern Trust

View all funds holding Aurinia Pharmaceuticals